Madatli F. I., Abbasalieva T. R., Hajiev Z. A.
LEVEL OF AWARENESS ABOUT COUNTERFEİT DRUGS
Show/Download
About the author:
Madatli F. I., Abbasalieva T. R., Hajiev Z. A.
Heading:
CLINICAL AND EXPERIMENTAL MEDICINE
Type of article:
Scientific article
Annotation:
The production and widespread distribution of counterfeit medicines in most countries of the world is unsafe for the health of consumers, causes economic damage, and therefore is a serious public health problem. In connection with the latter circumstance, an important role in countering the circulation of such drugs is the awareness of the subjects of circulation about their identification, their suppliers and the timely implementation of internal control measures. Constant monitoring of drug supplies and prompt notification of subjects of circulation about the detection of counterfeit drugs helps to identify and prevent the circulation of counterfeit drugs. That is, since counterfeit medicines are dangerous for the healthcare system and patients, it is important for doctors, pharmacists and the patients themselves who use them to be aware of them. From this point of view, in order to determine the level of public awareness of counterfeit medicines, we conducted a survey of 100 patients, including 24 men and 76 women. As a result of the study, the majority of participants, answering options in the questionnaire, came to the conclusion that the drug is counterfeit due to the lack of effect, and if a counterfeit drug is discovered, they will first of all “turn” to the pharmacist who sold the drug, and that the main responsibility for the turnover counterfeit medicines are the responsibility of medical companies, and they believed that educational work on medicines, including counterfeit ones, would be more effective through social networks and that doctors should participate more in educational campaigns.
Tags:
Bibliography:
- WHO. Substandard and falsified medical products. WHO; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/ substandard-and-falsified-medical-products.
- Sammons HM, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatr Open. 2017;1(1):e000007. DOI: 10.1136/bmjpo-2017-000007.
- Adigwe OP. Stakeholders’ perspective of role of policy and legislation in achieving medicines’ security. Int J World Pol Dev Stud. 2020;6(6):66-73. DOI: 10.32861/ijwpds.66.66.73.
- OECD/EUIPO. Misuse of Small Parcels for Trade in Counterfeit Goods: Facts and Trends. Paris: OECD Publishing; 2018. DOI: https://doi. org/10. 1787/9789264307858-en.
- Toklu HZ, Mensah E. Why do we need pharmacists in pharmacovigilance systems? Online J Public Health Inform. 2016;8(2):e193. DOI: 10.5210/ojphi.v8i2.6802.
- UNODC. World Drug Report 2023. UNODC: United Nations publication; 2023. Available from: https://www.unodc.org/unodc/en/data-andanalysis/ world-drug-report-2023.html.
- Pathak R, Gaur V. Tackling Counterfeit Drugs: The Challenges and Possibilities. Pharmaceut Med. 2023 Jul;37(4):281-290. DOI: 10.1007/ s40290-023-00468-w.
- Wagiella WW, Shantier SW, Gadkariem EA. Public Awareness and Attitude towards Counterfeit Medicines in Sudan: A cross-sectional study. Journal of Applied Pharmaceutical Science. 2022;12(06):115-121. DOI: .
- Yadav S, Rawal G. Counterfeit drugs: problem of developing and developed countries. Int J Pharm Chem Anal. 2015;2(1):46-50. DOI: https://doi.org/10. 1590/s2175-97902023e20402.
- UNESCO. Guide 4: Bioethics Committees and Public Policy. Paris: UNESCO. 2019. Available from: https: //unesdoc.unesco.org/ ark:/48223/ pf0000233230.
- Adigwe OP. The role of pharmacists in eliminating counterfeit medicines in Nigeria. Front Public Health. 2023 Aug 22;11:1170929. DOI: 10.3389/fpubh.2023.
Publication of the article:
«Bulletin of problems biology and medicine», 2023 Issue 4, 171, 228-232 pages, index UDC 615.12:009.33
